A. Smala

EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring

H. Heidbuchel, R. Peinado, L. Annemans, 2014, European heart journal.

Cost of atherothrombotic diseases—myocardial infarction, ischaemic stroke and peripheral arterial occlusive disease—in Germany

S. Willich, H. Rupprecht, A. Smala, 2005, Journal of Public Health.

Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective

A. Smala, J. Maervoet, N. Bossers, 2019, Journal of medical economics.

Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany

A. Smala, H. Diener, K. Berger, 2008, Current medical research and opinion.

Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK

H. Burri, A. Smala, C. Sticherling, 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study

D. Nowak, K. Berger, A. Smala, 2003, European Respiratory Journal.

Costs and quality of life in multiple sclerosis

P. Rieckmann, A. Bitsch, U. Zettl, 2001, The European Journal of Health Economics (HEPAC).

Costs and quality of life in multiple sclerosis

Peter Lindgren, Uwe K. Zettl, P. Rieckmann, 2001, The European Journal of Health Economics (HEPAC).

Reply: Cabergoline versus levodopa therapy

W. Oertel, U. Siebert, R. Dodel, 2004 .

[Economic evaluation of various hepatitis B vaccination strategies in children and adolescents].

A. Smala, T. Szucs, K. Berger, 1998, Medizinische Klinik.

Cabergoline versus levodopa monotherapy: A decision analysis

W. Oertel, U. Siebert, R. Dodel, 2003, Movement disorders : official journal of the Movement Disorder Society.

Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice.

A. Smala, J. Symanowski, A. Cordony, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus

H. Freund, P. Krack, J. Volkmann, 2002, Journal of Neurology.

[Costs of intensive insulin therapy in type 1 diabetes mellitus. Experiences from the DCCT study].

A. Smala, T. Szucs, T. Fischer, 1998, Fortschritte der Medizin.

Non-Invasive On-Line Investigations of Industry Style Bioreactors

Irving J. Dunn, Louis Tiefenauer, Michael R. Schuppenhauer, 1995 .